News
Videos
Conferences
Events
Resources
Subscribe

|Videos|December 1, 2020

ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

Author(s)Jonathan W. Riess, MD, MS, UC Davis Comprehensive Cancer Center

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Lung

Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status

BySpencer Feldman

June 3rd 2026

Image of conference

Top 5 Takeaways From ASCO 2026 That Patients Should Know

BySpencer Feldman

June 3rd 2026

Image of lungs.

Ivonescimab Extends Survival in Advanced Squamous Non-Small Cell Lung Cancer

May 31st 2026

Dr. Yasir Y. Elamin

ROS1 Lung Cancer Drug Ibtrozi May Improve Breathing and Quality of Life

May 31st 2026

Dr. Emily Podany

Food Deserts Link to Aggressive Breast Cancer Biology and Survival Gaps

May 31st 2026

Trending on CURE

Top 5 Takeaways From ASCO 2026 That Patients Should Know

Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status

Lynch Syndrome: Why Upper Endoscopies and Colonoscopy Prep Save My Life

How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments

Iza-Bren Improves Survival in Metastatic Triple-Negative Breast Cancer